Skip to main content

Advertisement

SpringerLink
Log in

MDS and GCA: a prognostic dilemma

  • Case Based Review
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

A number of autoimmune disorders, such as large vessel vasculitis, have been recognized in patients who have myelodysplastic syndrome (MDS) and myeloproliferative syndrome (MPS). The influence of an autoimmune disorder on the prognosis of patients who have MDS and MPS remains to be determined. We report three cases of myelodysplastic syndrome and large vessel vasculitis seen at our institution and provide a brief literature review of the two disease processes. More studies are needed to determine the pathophysiology of the underlying diseases and whether there truly is a relationship between the disease entities and to discover better markers for disease assessment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Berlin NI (1975) Diagnosis and classification of the polycythemias. Semin Hematol 12(4):339–351

    CAS  PubMed  Google Scholar 

  2. Savage JA, Chang L, Smith CL, Duggan JC (1993) Myelodysplasia, vasculitis and anti neutrophil cytoplasm antibodies. Leuk Lymphoma 9:49–55

    Article  Google Scholar 

  3. Landolfi R (1998) Bleeding and thrombosis in myeloproliferative disorders. Curr Opin Hematol 5(5):327–331

    Article  CAS  PubMed  Google Scholar 

  4. Streiff MB, Smith B, Spivak JL (2002) The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members’ practice patterns. Blood 99(4):1144–1149

    Article  CAS  PubMed  Google Scholar 

  5. Espinosa G, Font J, Muñoz-Rodríguez FJ, Cervera R, Ingelmo M (2002) Myelodysplastic and myeloproliferative syndromes associated with giant cell arteritis and polymyalgia rheumatica: a coincidental coexistence or a causal relationship? Clin Rheumatol 21(4):309–313

    Article  CAS  PubMed  Google Scholar 

  6. Dameshek W (1951) Some speculations on the myeloproliferative syndromes. Blood 6(4):372–375

    CAS  PubMed  Google Scholar 

  7. Tefferi A, Vainchenker W (2011) Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies. J Clin Oncol 29(5):573–582

    Article  CAS  PubMed  Google Scholar 

  8. Hasselbalch HC (2011) Perspectives on chronic inflammation in essential thrombocythemia, polycythemia vera, and myelofibrosis: is chronic inflammation a trigger and driver of clonal evolution and development of accelerated atherosclerosis and second cancer? Blood 119(14):3219–3225

    Article  Google Scholar 

  9. Hasselbalch H (1990) Idiopathic myelofibrosis: a clinical study of 80 patients. Am J Hematol 34(4):291–300

    Article  CAS  PubMed  Google Scholar 

  10. Kristinsson SY, Landgren O, Samuelsson J, Björkholm M, Goldin LR (2010) Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica 95(7):1216–1220

    Article  PubMed  PubMed Central  Google Scholar 

  11. Rondeau E, Solal-Celigny P, Dhermy D, Vroclans M, Brousse N, Bernard JF, Boivin P (1983) Immune disorders in agnogenic myeloid metaplasia: relations to myelofibrosis. Br J Haematol 53(3):467–475

    Article  CAS  PubMed  Google Scholar 

  12. Hasselbalch H, Nielsen H, Berild D, Kappelgaard E (1985) Circulating immune complexes in myelofibrosis. Scand J Haematol 34(2):177–180

    Article  CAS  PubMed  Google Scholar 

  13. Rizzi R, Pastore D, Liso A, Liuzzi GM, Dalena AM, Specchia G, Ricco R, Liso V (2004) Autoimmune myelofibrosis: report of three cases and review of the literature. Leuk Lymphoma 45(3):561–566

    Article  PubMed  Google Scholar 

  14. Barosi G, Magrini U, Gale RP (2010) Does auto-immunity contribute to anemia in myeloproliferative neoplasms (MPN)-associated myelofibrosis? Leuk Res 34(9):1119–1120

    Article  PubMed  Google Scholar 

  15. Weyand CM, Goronzy JJ (2003) Medium- and large-vessel vasculitis. N Engl J Med 349:160–169

    Article  CAS  PubMed  Google Scholar 

  16. Weyand CM, Liao YJ, Goronzy JJ (2012) The immunopathology of giant cell arteritis: diagnostic and therapeutic implications. J Neuroophthalmol 32:259–265

    Article  PubMed  PubMed Central  Google Scholar 

  17. Aiello PD, Trautmann JC, McPhee TJ, Kunselman AR, Hunder GG (1993) Visual prognosis in giant cell arteritis. Ophthalmology 100:550–555

    Article  CAS  PubMed  Google Scholar 

  18. Miller DV, Isotalo PA, Weyand CM, Edwards WD, Aubry MC, Tazelaar HD (2006) Surgical pathology of noninfectious ascending aortitis: a study of 45 cases with emphasis on an isolated variant. Am J Surg Pathol 30:1150–1158

    Article  PubMed  Google Scholar 

  19. Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, Miranda-Filloy JA, Gonzalez-Juanatey C, Martin J, Llorca J (2009) Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum 61:1454–14561

    Article  PubMed  Google Scholar 

  20. Crowson CS, Matteson EL, Myasoedova E, Michet CJ, Ernste FC, Warrington KJ, Davis JM 3rd, Hunder GG, Therneau TM, Gabriel SE (2011) The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum 63:633–639

    Article  PubMed  PubMed Central  Google Scholar 

  21. Zöller B, Li X, Sundquist J, Sundquist K (2013) Occupational and socio-economic risk factors for giant cell arteritis: a nationwide study based on hospitalizations in Sweden. Scand J Rheumatol 42:487–497

    Article  PubMed  Google Scholar 

  22. Weyand CM, Goronzy JJ (2013) Immune mechanisms in medium and large-vessel vasculitis. Nat Rev Rheumatol 9:731–740

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Pryshchep O, Ma-Krupa W, Younge BR, Goronzy JJ, Weyand CM (2008) Vessel-specific Toll-like receptor profiles in human medium and large arteries. Circulation 118:1276–1284

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Weyand CM, Younge BR, Goronzy JJ (2011) IFN-γ and IL-17: the two faces of T-cell pathology in giant cell arteritis. Curr Opin Rheumatol 23:43–49

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Deng J, Younge BR, Olshen RA, Goronzy JJ, Weyand CM (2010) Th17 and Th1 Tcell responses in giant cell arteritis. Circulation 121:906–915

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Weyand CM, Goronzy JJ (2014) Giant-cell arteritis and polymyalgia rheumatica. N Engl J Med 371(17):1653

    Article  PubMed  Google Scholar 

  27. Mukhtyar C, Guillevin L, Cid MC, Dasgupta B, de Groot K, Gross W, Hauser T, Hellmich B, Jayne D, Kallenberg CG, Merkel PA, Raspe H, Salvarani C, Scott DG, Stegeman C, Watts R, Westman K, Witter J, Yazici H, Luqmani R (2009) European Vasculitis Study Group. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 68:318–323

    Article  CAS  PubMed  Google Scholar 

  28. Salvarani C, Macchioni P, Manzini C, Paolazzi G, Trotta A, Manganelli P, Cimmino M, Gerli R, Catanoso MG, Boiardi L, Cantini F, Klersy C, Hunder GG (2007) Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. Ann Intern Med 146:631–639

    Article  PubMed  Google Scholar 

  29. Hoffman GS, Cid MC, Rendt-Zagar KE, Merkel PA, Weyand CM, Stone JH, Salvarani C, Xu W, Visvanathan S, Rahman MU, Infliximab-GCA Study Group (2007) Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. Ann Intern Med 146:621–630

    Article  PubMed  Google Scholar 

  30. Enright H, Miller W (1997) Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymphoma 24:483–489

    Article  CAS  PubMed  Google Scholar 

  31. Katsuyama T, Uchida HA, Toma K, Maeda Y, Hirota D, Umebayashi R, Sada KE, Makino H (2014) Large vessel vasculitis with myelodysplastic syndrome. Intern Med 53:63–66

    Article  PubMed  Google Scholar 

  32. Barrett AJ, Sloand E (2009) Autoimmune mechanisms in the pathophysiology of myelodysplastic syndromes and their clinical relevance. Haematologica 94:449–451

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Comarmond C, Plaisier E, Dahan K, Mirault T, Emmerich J, Amoura Z, Cacoub P, Saadoun D (2012) Anti TNF-in refractory Takayasu’s arteritis: cases series and review of the literature. Autoimmun Rev 11:678–684

    Article  CAS  PubMed  Google Scholar 

  34. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CGM, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DGI, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitis. Arthritis Rheum 65:1–11

    Article  CAS  PubMed  Google Scholar 

  35. Belizna C, Subra JF, Henrion D, Ghali A, Renier G, Royer M, Corre YL, Martin L, Voswinkel J, Ifrah N (2013) Prognosis of vasculitis associated myelodysplasia. Autoimmun Rev 10:943–946

    Article  Google Scholar 

Download references

Disclosures

None.

Author information

Authors and Affiliations

  1. Department of Rheumatology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA

    Neha G. Narula & Andy Abril

Authors
  1. Neha G. Narula
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andy Abril
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Neha G. Narula.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Narula, N.G., Abril, A. MDS and GCA: a prognostic dilemma. Clin Rheumatol 35, 807–812 (2016). https://doi.org/10.1007/s10067-015-2993-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-015-2993-z

Keywords

Search

Navigation